A surface Plasmon resonator is a device used in the development of new material, for instance in thin films, which is said to have the potential to increase the transmission of electrical signals. It also has applications beyond the production of thin films; it is possible to supercool metals using plasma generators. The device uses two metal foils separated by a non-metallic barrier to generate electric fields. These electric fields are induced between adjoining thin sheets of metals and the layers which are filled with various chemical compounds.
Increasing applications of SPR for research and development activities in the field of pharmaceuticals are expected to drive growth of the global surface Plasmon resonance market during the forecast period. R&D activities regarding drug discovery have increased over the years, typically due to rapid growth of the pharmaceutical industry in both developed and emerging economies. According to the India Brand Equity Foundation (IBEF), the Indian pharmaceuticals market is reached US$ 20.03 billion in 2019, increasing from US$ 18.12 billion in 2018 registering 9.8% y-o-y growth. SPR is mainly used in drug discovery to identify and optimize small molecules that combine to their target proteins with different binding affinities. Furthermore, proactive initiatives by regulatory authorities to boost R&D activities in the pharmaceutical sector is expected to increase the demand for SPR. For instance, in August 2020, The Ministry of Corporate Affairs (MCA) announced that pharmaceutical companies can use their corporate social responsibility (CSR) funds in R&D activities associated with new drugs, vaccines, and medical devices. Thus, these factors are expected to drive growth of the global surface Plasmon resonance market during the forecast period. Furthermore, growing use of SPR in the food industry for quantifications of vitamins in the food products is expected to boost the global surface Plasmon resonance market growth over the forecast period.
However, significant cost associated with installment and maintenance of SPR products coupled with a lack of skilled personnel in emerging economies is expected to hamper the global surface Plasmon resonance market growth over the forecast period. Among regions, North America is expected to witness significant growth in the global surface Plasmon resonance market during the forecast period. This is owing to the early adoption of the latest technologies in numerous sectors across the region. Furthermore, Asia Pacific is expected to register a robust growth rate over the forecast period, owing to increasing emphasis on the improvement of diagnosis and treatment procedures in the hospitals.
Key companies involved in the global surface Plasmon resonance market are Bio-Rad Laboratories, Inc., Biosensing Instrument Inc., Carterra Inc., Bruker, General Electric Co., Horiba, Ltd., AMETEK, Inc., and Bristol Myers Squibb.
For instance, in August 2020, Carterra Inc. introduced a new SARS-CoV-2 label-free assay for simultaneous measurement of IgG, IgA, and IgM, which is powered by surface Plasmon resonance (HT-SPR™) biosensor platform.
No comments:
Post a Comment